Category: News

Namocell Expands to Singapore Market with SingLab Distribution

Mountain View, Calif., (May 17, 2021) – Namocell Inc., a leading provider of high-performance single cell sorting and dispensing platforms, today announced it has entered into a distribution agreement with SingLab Technologies to distribute Namocell’s single cell isolation systems in Singapore. “There has been increasing demand for our Single Cell Dispenser systems in the Southeast […]

Namocell Partners with OLS to Expand Distribution to Germany and Austria

Mountain View, Calif., (March 18, 2021) – Namocell Inc., a leading provider of high-performance single cell sorting and dispensing platforms, today announced it has entered into a distribution agreement with Germany-based OLS OMNI Life Science to distribute Namocell’s Single Cell Dispensers in Germany and Austria. “There has been significant demand for our Single Cell Dispensers […]

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases

Palo Alto, Calif., (March 12, 2021) – HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) differentiated from adipose tissue-derived stromal cells (ASCs) using Namocell’s Single Cell Dispensers and Takara Bio’s SMART-seq® kits to characterize HepaTx’s […]

Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases

Mountain View, Calif., (February 20, 2020) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms, announced today that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells (iHeps) developed from adipose tissue-derived stromal […]

Namocell Appoints VP of Engineering

Mountain View, Calif., (October 30, 2019) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms to advance single cell research and development, announced that Dr. Bob Cao has joined the company as VP of Engineering. Bob brings over 20 years of engineering and innovation leadership experience. He spent 12 years at […]

Namocell Names New VP of Marketing and Business Development

Mountain View, Calif., (September 9, 2019) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms, today announced that Abe Couse has joined the company’s management team as VP of Marketing and Business Development. Abe brings over 20 years of life science commercial leadership experience in marketing, sales, business and product development, […]

Namocell Enters the Netherlands, Belgium and Luxembourg Market with BIOKÉ Distributorship

Mountain View, Calif., (July 25, 2018) – Namocell Inc., a leading provider of high-performance single cell dispensing and sorting platforms for life science applications, today announced it has entered into a distribution agreement with BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), to distribute Namocell’s Namo Single Cell Dispenser in the Netherlands, […]

Namocell Expands to Korea with MDxK Distribution Deal

Mountain View, Calif., (July 10, 2018) – Namocell recently announced that it has signed two separate distribution deals for its Namo Single Cell Dispenser tool with MDxK in South Korea and with Bioké in the Netherlands, Belgium, and Luxembourg. The firm’s microfluidic-based cell platform dispenses single cells into a 96-well plate in less than a […]

Namocell Signs Distribution Deal with Tomy Digital in Japan

Mountain View, Calif., (June 20, 2018)  –  Namocell announced today that it has signed an agreement with Tomy Digital Biology to distribute Namocell’s Namo Single Cell Dispenser in Japan. Financial details of the agreement were not disclosed. Namocell’s microfluidic-based cell platforms dispense single cells into a 96-well plate in less than a minute, the company […]

Namocell and MGH Collaborate on Circulating Tumor Cell Research

Mountain View, Calif., (December 16, 2016)  –  Namocell, a developer of microfluidic-based single-cell sorting and capturing platforms, has announced a collaboration with researchers at Massachusetts General Hospital to research circulating tumor cells. Namocell will work with the MGH team to isolate CTCs and CTC clusters from cancer patient blood samples using its Namo Single Cell […]